BNP Paribas Asset Management’s Sabra Healthcare REIT SBRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.88M | Buy |
149,850
+129,211
| +626% | +$2.55M | ﹤0.01% | 990 |
|
|
2025
Q4 | $390K | Buy |
20,639
+12,491
| +153% | +$232K | ﹤0.01% | 1279 |
|
|
2025
Q3 | $152K | Buy |
8,148
+3,183
| +64% | +$59.5K | ﹤0.01% | 796 |
|
|
2025
Q2 | $92K | Buy |
+4,965
| New | +$88.1K | ﹤0.01% | 941 |
|
|
2025
Q1 | – | Sell |
-246,950
| Closed | -$4.28M | – | 913 |
|
|
2024
Q4 | $4.28M | Sell |
246,950
-33,761
| -12% | -$616K | 0.01% | 596 |
|
|
2024
Q3 | $5.22M | Buy |
+280,711
| New | +$4.73M | 0.01% | 533 |
|
|
2024
Q2 | – | Sell |
-318,808
| Closed | -$4.71M | – | 985 |
|
|
2024
Q1 | $4.71M | Buy |
318,808
+123,966
| +64% | +$1.72M | 0.01% | 535 |
|
|
2023
Q4 | $2.78M | Sell |
194,842
-321,626
| -62% | -$4.57M | 0.01% | 617 |
|
|
2023
Q3 | $7.2M | Buy |
+516,468
| New | +$6.61M | 0.02% | 454 |
|
|
2022
Q4 | – | Sell |
-27,321
| Closed | -$358K | – | 923 |
|
|
2022
Q3 | $358K | Hold |
27,321
| – | – | ﹤0.01% | 839 |
|
|
2022
Q2 | $382K | Buy |
27,321
+6,102
| +29% | +$81.6K | ﹤0.01% | 869 |
|
|
2022
Q1 | $316K | Buy |
21,219
+815
| +4% | +$11.2K | ﹤0.01% | 821 |
|
|
2021
Q4 | $276K | Buy |
20,404
+4,424
| +28% | +$62.6K | ﹤0.01% | 868 |
|
|
2021
Q3 | $235K | Buy |
15,980
+836
| +6% | +$14.1K | ﹤0.01% | 856 |
|
|
2021
Q2 | $276K | Buy |
+15,144
| New | +$270K | ﹤0.01% | 865 |
|
|
2021
Q1 | – | Sell |
-11,652
| Closed | -$202K | – | 870 |
|
|
2020
Q4 | $202K | Buy |
+11,652
| New | +$186K | ﹤0.01% | 831 |
|
|
2020
Q2 | – | Sell |
-172,891
| Closed | -$1.89M | – | 837 |
|
|
2020
Q1 | $1.89M | Sell |
172,891
-27,297
| -14% | -$503K | 0.02% | 547 |
|
|
2019
Q4 | $4.27M | Sell |
200,188
-58,020
| -22% | -$1.3M | 0.03% | 492 |
|
|
2019
Q3 | $5.93M | Buy |
258,208
+148,101
| +135% | +$3.16M | 0.05% | 415 |
|
|
2019
Q2 | $2.17M | Buy |
110,107
+380
| +0.3% | +$7.4K | 0.02% | 553 |
|
|
2019
Q1 | $2.14M | Sell |
109,727
-73,541
| -40% | -$1.39M | 0.02% | 602 |
|
|
2018
Q4 | $3.01M | Buy |
183,268
+10,569
| +6% | +$213K | 0.03% | 535 |
|
|
2018
Q3 | $3.99M | Sell |
172,699
-175,685
| -50% | -$3.98M | 0.03% | 514 |
|
|
2018
Q2 | $7.57M | Sell |
348,384
-98,584
| -22% | -$1.93M | 0.06% | 395 |
|
|
2018
Q1 | $7.89M | Sell |
446,968
-283,590
| -39% | -$5M | 0.07% | 383 |
|
|
2017
Q4 | $13.7M | Buy |
730,558
+37,830
| +5% | +$752K | 0.12% | 250 |
|
|
2017
Q3 | $15.2M | Buy |
692,728
+347,662
| +101% | +$7.85M | 0.13% | 214 |
|
|
2017
Q2 | $8.32M | Buy |
+345,066
| New | +$8.77M | 0.07% | 357 |
|
|
2016
Q2 | – | Sell |
-268,520
| Closed | -$5.39M | – | 1106 |
|
|
2016
Q1 | $5.39M | Sell |
268,520
-166,180
| -38% | -$3.19M | 0.05% | 445 |
|
|
2015
Q4 | $8.79M | Sell |
434,700
-118,862
| -21% | -$2.5M | 0.07% | 328 |
|
|
2015
Q3 | $12.8M | Buy |
553,562
+252,166
| +84% | +$6.43M | 0.11% | 263 |
|
|
2015
Q2 | $7.76M | Sell |
301,396
-326,522
| -52% | -$9.27M | 0.06% | 392 |
|
|
2015
Q1 | $20.8M | Buy |
627,918
+272,162
| +77% | +$8.83M | 0.16% | 191 |
|
|
2014
Q4 | $10.8M | Buy |
355,756
+49,032
| +16% | +$1.35M | 0.09% | 293 |
|
|
2014
Q3 | $7.46M | Buy |
306,724
+113,178
| +58% | +$3.14M | 0.06% | 344 |
|
|
2014
Q2 | $5.56M | Buy |
+193,546
| New | +$5.62M | 0.04% | 432 |
|
|
2014
Q1 | – | Sell |
-18,915
| Closed | -$494K | – | 937 |
|
|
2013
Q4 | $494K | Buy |
+18,915
| New | +$488K | ﹤0.01% | 772 |
|
Other funds holding SBRA
VPM
VCM
N
BNP Paribas Asset Management's SBRA Position: Q1 2026 in Review
BNP Paribas Asset Management increased its Sabra Healthcare REIT (SBRA) stake by 626% in Q1 2026, buying an estimated $2.55M and bringing the position to 149,850 shares worth $2.88M. The position accounts for ﹤0.01% of the portfolio, ranked #990.
BNP Paribas Asset Management first reported a position in SBRA in Q4 2013 and has held it in 37 quarters since. The position peaked at $20.8M in Q1 2015. 459 funds tracked by Wall St. Rank hold SBRA as of Q1 2026.
- BNP Paribas Asset Management held 149,850 shares of Sabra Healthcare REIT worth $2.88M as of Q1 2026.
- BNP Paribas Asset Management bought 129,211 Sabra Healthcare REIT shares in Q1 2026, an estimated $2.55M.
- Sabra Healthcare REIT made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q1 2026, its #990 holding.
- BNP Paribas Asset Management first reported a position in Sabra Healthcare REIT in Q4 2013 and has held it in 37 quarters since.
- BNP Paribas Asset Management's Sabra Healthcare REIT position peaked at $20.8M in Q1 2015.
- 459 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2026.
Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.